Donghwa Kim

机构：Seoul National University, University of California, San Francisco, Chan Zuckerberg Initiative (United States), UCSF Helen Diller Family Comprehensive Cancer Center · ORCID：0000-0003-1425-213X

发表论文 119 篇 · 总被引 1713 次 · h-index 23

代表论文

• Acquired resistance in cancer: towards targeted therapeutic strategies (2025 · Nature reviews. Cancer · 被引 108)
• Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer (2025 · eLife · 被引 5)
• Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer (2024 · eLife · 被引 5)
• Antiproliferative Activity of Gibbosic Acid H through Induction of G0/G1 Cell Cycle Arrest and Apoptosis in Human Lung Cancer Cells (2023 · Journal of Cancer Prevention · 被引 3)
• Combinatorial CRISPR screen reveals FYN and KDM4 as targets for synergistic drug combination for treating triple negative breast cancer (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Actionable biological programs to enhance EGFR-targeted therapy response unveiled by single-cell lineage tracing in clinically relevant lung cancer models (2025 · bioRxiv (Cold Spring Harbor Laboratory))